Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.
about
Comparison of the effects of estradiol and progesterone on serotonergic functionIdentification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleostsEstrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer.Gaining ligand selectivity in thyroid hormone receptors via entropySKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids.The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors.Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsiesBlocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding.ESR1 and ESR2 differentially regulate daily and circadian activity rhythms in female mice.Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vesselsRapid effects of estrogen on intracellular Ca2+ regulation in human airway smooth muscle.Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.Discovering small-molecule estrogen receptor α/coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency.Differential requirements of Hsp90 and DNA for the formation of estrogen receptor homodimers and heterodimers.17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's preventionGenome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.Kinetic analysis of estrogen receptor/ligand interactions.Gender-specific reduction in contraction is associated with increased estrogen receptor expression in single vascular smooth muscle cells of female rat.Alternative inhibition of androgen receptor signaling: peptidomimetic pyrimidines as direct androgen receptor/coactivator disruptors.Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor β-selective ligands.Probing the topological tolerance of multimeric protein interactions: evaluation of an estrogen/synthetic ligand for FK506 binding protein conjugate.DHEA metabolites activate estrogen receptors alpha and betaDevelopment of a transient expression assay for detecting environmental oestrogens in zebrafish and medaka embryos.Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors.Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells.Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes.Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat.Estrogen receptor β ligands: recent advances and biomedical applications.Membrane-initiated non-genomic signaling by estrogens in the hypothalamus: cross-talk with glucocorticoids with implications for behavior.The 2010 Philip S. Portoghese Medicinal Chemistry Lectureship: addressing the "core issue" in the design of estrogen receptor ligandsEstrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor.Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met.Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens.
P2860
Q24614252-270971EB-9F4A-414A-B94E-787E3B64B3BFQ24649916-2EA16930-00CF-4480-B888-DEBE0E28ABB3Q24800731-C8AED612-338F-4543-9235-F54822E9B584Q27658273-656A7DC8-6D1C-4AE7-9CC8-377498AEE32DQ28204373-F42C655B-9977-48E7-83CF-6BCF32DD3E1DQ30452982-31EC2DCC-749E-400F-A3FC-6E22978D9726Q30486738-FFD5D320-11E1-4826-B7F2-E4F7EE0E0C6AQ31040434-4DF65A88-CC2B-466A-AA28-D516C35B4843Q33368775-54654A01-6074-4026-B2C6-31ABDAC53225Q33569612-1484E1D9-38B6-49CD-BCD7-4701425943E6Q33572292-7CE23E7B-1C37-48C1-A6CC-470F2B5CAE9EQ33642747-81430B3C-95D5-4DF3-B8D1-890E09958265Q33761774-F263CA68-3A83-40EE-9FEA-04B227BEE0D7Q33781367-FF0C6AA0-A443-48FA-A9C6-BE751AFD3208Q33784130-685C1129-8A07-42A3-9A58-FC8E936DC009Q33786755-E80EE6FA-3CE0-40DE-9ED4-3CFB13C6ABA9Q33834493-F2D9B752-4D77-4C64-A62D-40656425F1DEQ33855236-D256B873-88E8-489C-A634-8A1177A80E58Q33927741-F882EEF9-440A-4A80-8180-1ABD91C8DB20Q34045766-CC75963F-EAD3-49B8-909C-5AE64ABE6486Q34064957-60FAFDA1-5F2D-4F4A-A4EC-CA21EFFF76B5Q34090934-B089BDD1-4C41-44FD-AB5E-7481F73AF26EQ34140002-C8830F9D-5A37-42FF-8CD3-DF6E03DB44F6Q34236388-42E36DA4-5349-433B-A954-91B5C48C9A5BQ34257756-4DCB7265-5F42-4A0F-8BEF-E417F666F050Q34309799-817DAB29-9A86-43E0-9073-52BB0A615101Q34315162-AC2C145D-332A-422A-AD1D-65A94A0045ACQ34315419-ACF2A8C8-36DD-4736-8295-8D9F630F5D22Q34440071-2F32538A-2B49-4237-BA15-8E7A848B9A8EQ34553671-5738B501-CED4-4A47-A648-D3977ACAF6C4Q34651821-D93197FC-EE18-4A54-8C47-4C11C5377231Q34930830-A9AC1E68-7935-4BE7-BB37-3394C93AF4B4Q34946607-7074B756-4448-410F-8D01-FE3933F6C0DFQ35016384-6A9948BC-E3A2-4FAB-9F3C-9C315C06E521Q35087316-69E9BF20-301F-436B-AB25-B521579D0FF6Q35148605-9E4708E9-5D4D-4C07-B6D2-C8CDFAADE418Q35230714-473D8659-4258-4A7C-BDD8-82708048FFFAQ35641926-88DDEE7C-4D41-46A5-BEE8-14C609B905B2Q35712301-4612FFB4-ED45-4B64-A41C-29099F42A8DBQ35748083-2013ADD9-C817-4F5E-92F3-9EA1A40BF670
P2860
Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Novel ligands that function as ...... pha or estrogen receptor-beta.
@ast
Novel ligands that function as ...... pha or estrogen receptor-beta.
@en
Novel ligands that function as ...... pha or estrogen receptor-beta.
@nl
type
label
Novel ligands that function as ...... pha or estrogen receptor-beta.
@ast
Novel ligands that function as ...... pha or estrogen receptor-beta.
@en
Novel ligands that function as ...... pha or estrogen receptor-beta.
@nl
prefLabel
Novel ligands that function as ...... pha or estrogen receptor-beta.
@ast
Novel ligands that function as ...... pha or estrogen receptor-beta.
@en
Novel ligands that function as ...... pha or estrogen receptor-beta.
@nl
P2093
P356
P1433
P1476
Novel ligands that function as ...... pha or estrogen receptor-beta.
@en
P2093
Katzenellenbogen BS
Katzenellenbogen JA
Rajendran R
P304
P356
10.1210/EN.140.2.800
P407
P577
1999-02-01T00:00:00Z